AI assistant
Sending…
INSMED Inc — Director's Dealing 2016
Nov 18, 2016
30150_dirs_2016-11-18_224318ab-4559-403d-8e29-739f3c5f9956.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2016-11-17
Reporting Person: Drechsler Andrew T (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-17 | Common Stock | M | 5000 | $6.65 | Acquired | 5000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-17 | Stock Option | $6.65 | M | 5000 | Disposed | 2022-11-07 | Common Stock (5000) | Direct |
Footnotes
F1: Stock options granted under the Company's 2000 Stock Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
More from INSMED Inc
Regulatory Filings
2026
May 15
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Report Publication Announcement
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 19